BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27473796)

  • 21. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.
    Yeoh A; Wong R; Singal AK
    Clin Liver Dis; 2023 May; 27(2):413-427. PubMed ID: 37024216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons.
    Jorge JM; Golas A; Patel N; Gonzalvo JP; Murr MM
    Surg Obes Relat Dis; 2020 May; 16(5):699-703. PubMed ID: 32151552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease.
    Abu Dayyeh BK; Bazerbachi F; Graupera I; Cardenas A
    J Hepatol; 2019 Dec; 71(6):1246-1248. PubMed ID: 31570275
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Buzzetti E; Pinzani M; Tsochatzis EA
    Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Targher G; Byrne CD
    Metab Syndr Relat Disord; 2015 Aug; 13(6):235-8. PubMed ID: 25714786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery.
    Loy JJ; Youn HA; Schwack B; Kurian M; Ren Fielding C; Fielding GA
    Surg Obes Relat Dis; 2015; 11(2):442-9. PubMed ID: 25820083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery.
    Selby LV; Ejaz A; Brethauer SA; Pawlik TM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):107-110. PubMed ID: 31986920
    [No Abstract]   [Full Text] [Related]  

  • 32. Bariatric surgery and nonalcoholic fatty liver disease.
    Bower G; Athanasiou T; Isla AM; Harling L; Li JV; Holmes E; Efthimiou E; Darzi A; Ashrafian H
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):755-68. PubMed ID: 25919774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key genes involved in nonalcoholic steatohepatitis improvement after bariatric surgery.
    Chen X; Deng SZ; Sun Y; Bai Y; Wang Y; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1338889. PubMed ID: 38469144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic Fatty Liver Disease.
    Thrasher T; Abdelmalek MF
    N C Med J; 2016; 77(3):216-9. PubMed ID: 27154894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of bariatric surgery on nonalcoholic steatohepatitis.
    Rabl C; Campos GM
    Semin Liver Dis; 2012 Feb; 32(1):80-91. PubMed ID: 22418890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.
    Anstee QM; Day CP
    Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.
    Marchisello S; Di Pino A; Scicali R; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin in nonalcoholic fatty liver disease: a narrative review.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):60-78. PubMed ID: 25456097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.